Lovastatin

Contraindicated

Lovastatin Ketoconazole Topical Extina® Foam Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Amprenavir Increased plasma levels of lovastatin and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Atazanavir Reyataz Increased risk of lovastatin toxicity, including an increased risk of myopathy or rhabdomyolysis Details Lovastatin Boceprevir Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as risk of myopathy and rhabdomyol... Details Lovastatin Ceritinib Zykadia Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Clarithromycin Biaxin An increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Cobicistat Tybost Increased risk of lovastatin toxicity and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Darunavir Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Dasabuvir Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as risk of myopathy and rhabdomyol... Details Lovastatin Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details Lovastatin Erythromycin Erythrocin Stearate Increased lovastatin exposure, an increased risk of lovastatin-related adverse reaction and an increased risk of myopathy or rhabd... Details Lovastatin Fosamprenavir Lexiva An increased risk of myopathy or rhabdomyolysis Details Lovastatin Idelalisib Zydelig Increased lovastatin exposure and an increased risk of myopathy and rhabdomyolysis Details Lovastatin Indinavir Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Itraconazole Sporanox Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as an increased risk of myopathy a... Details Lovastatin Ketoconazole Extina Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Levoketoconazole Recorlev Increased CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related adverse reaction Details Lovastatin Lonafarnib Zokinvy Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Lopinavir An increased risk of myopathy or rhabdomyolysis Details Lovastatin Mibefradil An increased risk of myopathy and/or rhabdomyolysis Details Lovastatin Mifepristone Korlym Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as, myopathy and rhabdomyolysis Details Lovastatin Nefazodone Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as, risk of myopathy or rhabdomyol... Details Lovastatin Nelfinavir Viracept Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as, risk of myopathy or rhabdomyol... Details Lovastatin Nirmatrelvir Increased risk of myopathy or rhabdomyolysis Details Lovastatin Ombitasvir Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as risk of myopathy and rhabdomyol... Details Lovastatin Paritaprevir Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as risk of myopathy and rhabdomyol... Details Lovastatin Posaconazole Noxafil Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Ribociclib Kisqali Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Ritonavir Norvir Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as an increased risk of myopathy o... Details Lovastatin Saquinavir Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as, increased risk of myopathy or... Details Lovastatin Telaprevir Increased lovastatin exposure and an increased risk of lovastatin-related adverse effects, such as, risk of myopathy or rhabdomyol... Details Lovastatin Telithromycin Increased lovastatin plasma levels and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Tipranavir Aptivus An increased risk of myopathy or rhabdomyolysis Details Lovastatin Troleandomycin Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Tucatinib Tukysa Increased lovastatin exposure and an increased risk of myopathy or rhabdomyolysis Details Lovastatin Voriconazole Vfend Increased plasma levels of lovastatin and an increased risk of myopathy or rhabdomyolysis Details

Major

Lovastatin Colchicine Colcrys An increased risk of myopathy, including rhabdomyolysis Details Lovastatin Cyclosporine Injection Atopica Increased lovastatin exposure and an increased risk of myopathy and rhabdomyolysis Details Lovastatin Cyclosporine Ophthalmic Cequa Increased lovastatin exposure and an increased risk of myopathy and rhabdomyolysis Details Lovastatin Danazol Danocrine® An increased risk of myopathy or rhabdomyolysis Details